Key Takeaways
- Fertilizer segment hit by margin collapse: Sales value rose 55% YoY on DAP special package realizations, but EBIT crashed from ₹224 crores to ₹17 crores as raw material costs spiked sharply.
- Industrial products delivered the quarter's resilience: Sales up 30% YoY, EBIT up 22%, powered by a Caprolactam-Benzene spread that widened from US$512/MT to US$849/MT and better realizations across major products.
- Subsidy dependency is the central risk: Management stated plainly that without subsidy there is no margin in fertilizers, and the urea subsidy rate remains unresolved pending a pool gas rate decision pending since April 2026.
- A ₹3,000 crores backward-integration bet: The newly finalized sulphuric acid plant at Sikka targets a comfortable 20% margin by replacing purchased phosphoric and sulphuric acid, with a 32–33 month timeline to completion.
- What to watch next quarter: Whether the government approves increased NBS subsidy rates effective 1 October 2026, which management says would compensate the deficit incurred in the last quarter, and whether the Caprolactam-Benzene spread moderates as regional supply normalizes.
Fertilizer Segment: The Subsidy Squeeze
- Top-line growth masked the damage: A 55% YoY sales value jump (+₹1,387 crores) was driven entirely by higher DAP realization (+₹1,659 crores) from the government's special package, while volumes actually declined 6% from 6.08 lakh MT to 5.69 lakh MT.
- Raw material costs crushed margins: Sulphur prices rose 327% and natural gas rose 62%, driving EBIT down from ₹224 crores to just ₹17 crores. The company used agility in product mix and timely pricing actions to defend what it could, but the subsidy mechanism is the true margin driver.
- Urea subsidy rate in limbo: The rate remains subject to revision pending finalization of the actual pool gas rate by FICC, a decision pending since April 2026. Without clarity, margin planning is effectively on hold.
- Demand headwinds are stacking up: The country enters the rainy season with the highest fertilizer inventory levels in three years, especially urea and PK grades, intensifying competitive pressure. A subdued southwest monsoon and lower reservoir levels, particularly in southern India, are likely to constrain demand further.
- DAP-NPK price distortion persists: The prevailing price gap between DAP and NPK fertilizers continues to skew farmer purchase preferences, adversely affecting NPK uptake. Management pins hope on forthcoming NBS subsidies to address the distortion.
S.K. Bajpai: "The subsidy is very important because whatever margins are coming, it is from subsidy. If the subsidy goes out, then there is no margin in any of the fertilizers."
Industrial Products: The Margin Anchor
- Broad-based strength across the portfolio: Segment sales rose 30% (+₹185 crores) and EBIT moved from ₹54 crores to ₹66 crores. Caprolactam and Nylon-6 gained on higher realizations, ammonia gained on higher volumes, and TGU sales also increased, partly offset by a decline in melamine.
- Caprolactam-Benzene spread was the star: The spread improved from US$512/MT to US$849/MT, a 66% expansion that powered IP segment performance. Management expects this to moderate in Q3 FY27 as regional supply normalizes, which would pressure margins across the Caprolactam-Nylon value chain.
- Structural margin advantage over fertilizers: The IP segment carries no MRP control, unlike fertilizers, and the company uses captive raw material consumption and product mix optimization to capture margin. Management sees better prospects in IP going forward for exactly this reason.
- Steady baseline ahead: Demand for Melamine and Technical Grade Urea is expected to remain steady, HX crystal exports may improve, and other industrial products are projected to maintain steady demand amid subdued domestic conditions, delivering reliable baseline stability.
S.K. Bajpai: "We have a better margin in fact in the chemical side because there is no control in the MRP or something like that as in case of the fertilizers."
Strategic Projects: The Backward-Integration Bet
- PSA project at Sikka finalized: The company has committed to a sulphuric acid production project at around ₹3,000 crores, aimed at reducing dependence on volatile international phosphoric acid and sulphuric acid prices. The project timeline is 32–33 months to completion.
- The margin math: Management sees a comfortable 20% margin by going the phosphoric acid production route rather than purchasing phosphoric acid and sulphuric acid on the open market. The project is a structural hedge against the raw material volatility that just devastated the fertilizer segment.
- APS production modification live: A 3-ton modification enabling 1,200 MTPD APS production in place of DAP at the Sikka unit was commissioned on 23rd October 2026, adding production flexibility.
S.K. Bajpai: "Presently we see that it has a comfortable, uh, 20% margin if we go by the PA production route rather than the purchasing of phosphoric acid and sulphuric acid."
Cost Efficiency & BCG Strategy
- BCG growth strategy in motion: Cost-cutting measures based on BCG-suggested growth strategy are being applied at the Sikka plant. Management expects these to be fruitful in H2 FY27.
- Quantified gains, but margin impact unclear: Around ₹20–25 crores per quarter in gains is expected from efficiency measures, specifically power purchase optimization at Sikka. Management declined to translate this into a margin percentage, stating the gains will be distributed among all products, making the percentage impact difficult to determine.
- Geopolitical easing as a wildcard: Any easing of geopolitical tensions in the Middle East and Europe could soften international raw material prices and provide relief to industry margins, though this is entirely outside the company's control.
Capital Allocation: No Buyback on the Table
- Buyback query deflected: When asked what kind of value creation exercise the board can envisage, management responded that there is no discussion in the board on buyback or other measures, and they will discuss at appropriate levels and come back. The answer carried no commitment and no timeline.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Subsidy-driven profit recovery | Deficit in profits incurred in Q2 will be compensated in the next quarter, if government approves increased subsidy rates effective 1 Oct 2026. | Q3 FY27 (conditional on government approval) |
| Cost-cutting gains | ₹20–25 crores per quarter from efficiency measures at Sikka plant (power purchase optimization). | H2 FY27 |
| PSA project completion | Sulphuric acid production plant at Sikka, ~₹3,000 crores investment. | 32–33 months |
| Caprolactam-Benzene spread | Expected to moderate as regional supply normalizes. | Q3 FY27 |
| H2 FY27 overall outlook | Management expects H2 to be "very good" for the company; cost-cutting measures will be fruitful. | H2 FY27 |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Consolidated sales growth | 49% YoY |
| Consolidated sales revenue | ₹8,324 cr, +55% YoY |
| Consolidated PBT | ₹249 cr, +22% (QoQ or sequential); down 26% YoY |
| Consolidated PAT | ₹200 cr, +26% (QoQ or sequential); down 22% YoY |
| Standalone sales | ₹4,711 cr, +50% YoY; highest-ever Q2 top line |
| H1 FY27 standalone sales | ₹8,293 cr, +56% YoY; highest-ever H1 top line |
| Fertilizer segment sales growth | 55% YoY, sales value up ₹1,387 cr |
| Fertilizer segment sales volume | 5.69 lakh MT, -6% YoY from 6.08 lakh MT |
| Fertilizer segment EBIT | ₹17 cr, vs ₹224 cr in Q2 FY26 |
| DAP revenue increase | ₹1,659 cr, driven by government DAP special package |
| Sulphur raw material cost increase | 327% |
| Natural gas raw material cost increase | 62% |
| Industrial products segment sales growth | 30% YoY, sales up ₹185 cr |
| Industrial products segment EBIT | ₹66 cr, vs ₹54 cr in Q2 FY26 |
| Caprolactam-Benzene spread | US$849 per MT, up from US$512 per MT in Q2 FY26 |
| DAP margin | 4% |
| Urea margin | 3–4% |
| PSA project capex at Sikka | ₹3,000 cr |
| PSA project captive consumption coverage | 50% of total DAP and NPK requirement for captive consumption |
| PSA project completion timeline | 32–33 months |
| Cost-cutting gains expected at Sikka | ₹20–25 cr per quarter |